Business
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
SOPHIA ANTIPOLIS, France, February 18, 2026--Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218440005/en/
About this update from Median Technologies
[{"type":"image","alt":"Oran Muduroglu Appointed President of Median eyonis Inc.","displaySize":"","headline":null,"caption":"Oran Muduroglu Appointed President of Median eyonis Inc.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":360,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/bcd68d2ea1f509a5e70c9a69a0f78d40"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/eoYDsn3yTjclyMee1BOTNA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTk0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/bcd68d2ea1f509a5e70c9a69a0f78d40","width":360,"height":480}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1240,"height":461,"url":"https://media.zenfs.com/en/business-wire.com/35c46ad0bb767d301fee1e28ec995b72"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/z8aQ7Em0ifKyltHjDrE7kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1NztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/35c46ad0bb767d301fee1e28ec995b72","width":960,"height":357},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/EodfHP9qXYTVh3AoErfHZA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04OTI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/35c46ad0bb767d301fee1e28ec995b72","width":1200,"height":446}}},{"type":"list","items":[{"val":[{"type":"text","content":"Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis® LCS","length":87,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway already in place to support expansion","length":138,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Active discussions underway to establish key clinical partnerships to support broad access across U.S. lung cancer screening programs","length":133,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Webcasts will be held on February 26, 2026, to discuss the Company’s recent achievements and upcoming milestones for eyonis® LCS deployment in the U.S.","length":151,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":509,"olType":false},{"type":"text","content":"SOPHIA ANTIPOLIS, France, February 18, 2026--(BUSINESS WIRE)--Regulatory News:","length":78,"tagName":"p"},{...